Aphex BioCleanse Systems Inc Files for Bankruptcy Protection under Chapter 11, Subchapter V
Aphex BioCleanse Systems Inc Files for Bankruptcy Protection under Chapter 11, Subchapter V
Venice, FL, May 19, 2022 (GLOBE NEWSWIRE) -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST), has filed a voluntary petition under the Federal Bankruptcy Code, Chapter 11, Subchapter V. The Petition was filed on May 12, 2022 in the United States Bankruptcy Court Middle District of Florida Tampa Division.
威尼斯，佛羅裏達州，2022年5月19日(Global Newswire)--Aphex BioCleanse Systems，Inc.(OTCPK：SNST)已根據聯邦破產法第11章第五小節提交了一份自願請願書。請願書於2022年5月12日在佛羅裏達州坦帕市中區美國破產法院提交。
The filing was precipitated by the litigatory actions of certain former Directors and Officers that while unfounded have damaged the business integrity of the Company and endangered the Company's shareholders as well as inhibiting the ability of the Company to raise working capital and market its products.
該申請是由某些前董事和高級管理人員的訴訟行為引發的，這些訴訟行為雖然沒有根據，但損害了公司的商業誠信，危及公司股東，並抑制了公司籌集營運資金和營銷其產品的能力。
The actions of these persons have included illegal and unfounded filings in Nevada, and numerous erroneous and illegal emails and communications designed to misinform Company Shareholders and Distributors. This includes the Former CEO and Chairman executing false documents impersonating the CEO and other Officer Titles of the Company MONTHS after being terminated for cause. This former CEO is now instrumental in leading the attempts to damage and take over the company.
這些人的行為包括在內華達州非法和毫無根據的文件，以及許多錯誤和非法的電子郵件和通訊，旨在誤導公司股東和分銷商。這包括前首席執行官和董事長在被因故解僱幾個月後假冒公司首席執行官和其他高級管理人員頭銜執行虛假文件。這位前首席執行官現在在領導破壞和接管公司的努力中發揮了重要作用。
Aphex plans to submit a timely reorganization plan and seek Debtor in Possession Financing to drive the marketing of its unique sanitizing water known as Hy-IQ and related products.
Aphex計劃及時提交重組計劃，並尋求債務人佔有融資，以推動其獨特的消毒水Hy-IQ和相關產品的營銷。
About Aphex BioCleanse Systems, Inc. (Aphex):
關於Aphex BioCleanse Systems公司(Aphex)：
Aphex is the developer of the world's first proprietary non-alcohol, non-toxic, hydrogen-based cleaning technology, and has been producing germ killing solutions for over 10 years. The technology, called Hy-IQ® Water, has a unique method of sanitizing that you won't find anywhere else. Hy-IQ® Water uses hydrogen ions traveling nearly at the speed of light to breach the cell walls of exoskeleton germs.
Aphex是世界上第一個專有的無酒精、無毒、基於氫氣的清潔技術的開發商，10多年來一直在生產殺菌解決方案。這項名為Hy-IQ的技術®水，有一種獨特的消毒方法，你在其他地方找不到的。HY-IQ®水利用氫離子以接近光速的速度穿透外骨骼細菌的細胞壁。
"We Kill Germs with Physics, Not Chemistry" is a tagline that expresses their commitment to the environment by providing non-Chemical solutions to the spread of dangerous pathogens. Killing the most dangerous germs on the planet, while meeting the EPA's definition of "Water", is revolutionary.
“我們用物理而不是化學殺死細菌”是一句標語，通過為危險病原體的傳播提供非化學解決方案來表達他們對環境的承諾。消滅地球上最危險的細菌，同時滿足環境保護局對“水”的定義，是一種革命性的做法。
To find out more about Aphex and their technologies, visit Aphex BioCleanse Systems, Inc. - Superior Sanitization (aphexus.com)
欲瞭解更多有關Aphex及其技術的信息，請訪問Aphex BioCleanse Systems，Inc.-Superior Sanitiization(apexus.com)。
Forward Looking Statements:
前瞻性陳述：
This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future, including but not limited to, any products sold or cash flow from operations. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
本新聞稿包含“前瞻性陳述”，這一術語在1933年的美國證券法第27A節和1934年的證券交易法第21E節中有定義。本新聞稿中非純粹歷史性的陳述為前瞻性陳述，包括有關對未來的信念、計劃、預期或意圖的任何陳述，包括但不限於已售出的任何產品或來自運營的現金流。由於許多因素，實際結果可能與任何前瞻性陳述中預測的結果不同。這些因素除其他外，包括與分銷有關的內在不確定性，以及與以可接受的條件獲得融資有關的困難。這些前瞻性陳述是截至本新聞稿發佈之日作出的，我們沒有義務更新前瞻性陳述，也沒有義務更新實際結果可能與前瞻性陳述中預測的結果不同的原因。儘管我們相信本新聞稿中包含的信念、計劃、預期和意圖是合理的，但不能保證這些信念、計劃、預期或意圖將被證明是準確的。投資者應參考本文中列出的所有信息，也應參考我們上一財年的最新年度報告、我們的季度報告以及不定期向美國證券交易委員會提交的其他定期報告。
Investor Contact:
投資者聯繫方式：
Anthony Marrotti
585-880-1567
安東尼·馬羅蒂
585-880-1567
譯文內容由第三人軟體翻譯。